HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van Os, R. Articles by Mauch, P. M. Search for Related Content PubMed PubMed Citation Articles by van Os, R. Articles by Mauch, P. M.

Immunogenicity of Ly5 (CD45)-Antigens Hampers Long-Term Engraftment Following Minimal Conditioning in a Murine Bone Marrow Transplantation Model

^a Department of Radiation Oncology, Brigham and Women's Hospital and the Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA;
^b Combined Bone Marrow Transplantation Program, University of Michigan Cancer Center, Ann Arbor, Michigan, USA

Key Words. Engraftment • Gpi • Ly5 • Immunity

Ronald van Os, Ph.D., Department of Hematology, Leiden University Medical Center Building 1, C2-R, PO Box 9600, 2300 RC Leiden, The Netherlands. Telephone: 31-71-5262271; Fax: 31-71-5266755.

Various techniques are available for distinguishing donor from host cells evaluating the efficacy of conditioning regimen for experimental bone marrow transplantation (BMT). Techniques include the use of extracellular immunological markers, such as Ly5 (CD45), and intracellular biochemical markers, such as glucose-phosphate-isomerase (Gpi). Because Ly5 is an extracellular protein, the disparity between donor (Ly5.1) and host (Ly5.2) antigens may induce a weak immune response whereas with Gpi, no immune response is expected. This difference may be of particular concern in experimental transplantation approaches that use minimal conditioning such as low-dose total body irradiation (TBI). Such mild conditioning may not induce the immunosuppression required to overcome host rejection of Ly5 disparate cells.

To compare the relative engraftment of Ly5.1 and Gpi-1^a donor marrow, B6 (Gpi-1^b/Ly5.2) mice were irradiated with low-level TBI (0-6 Gy) and transplanted with several bone marrow (BM) doses (2 x 10⁶-5 x 10⁷ cells). At 8, 26, and 52 weeks post-BMT, the level of donor engraftment was measured using flow cytometry (Ly5) or Gpi-electrophoresis.

Lower engraftment levels were found in mice transplanted with Ly5 congenic BM in groups given low-dose TBI (4 Gy) and/or low doses of BM cells (BMC) (2 x 10⁶). However, when higher TBI or BMC doses were used, similar engraftment levels were found, suggesting sufficient immune suppression to allow equal engraftment of both sources of BM.

These data suggest that even a minor phenotypic disparity between donor and host, such as Ly5, may necessitate high-dose TBI to prevent rejection. The combination of low-dose TBI or other nonmyeloablative conditioning strategies with small numbers of BMC may lead to reduced engraftment when extracellular immunological markers such as Ly5 are used for transplantation studies. Therefore, small immunological differences must be considered when using the Ly5 marker for engraftment.

This article has been cited by other articles:

				J. Chen, A. Larochelle, S. Fricker, G. Bridger, C. E. Dunbar, and J. L. Abkowitz Mobilization as a preparative regimen for hematopoietic stem cell transplantation Blood, May 1, 2006; 107(9): 3764 - 3771. [Abstract] [Full Text] [PDF]

				D. Bhattacharya, D. J. Rossi, D. Bryder, and I. L. Weissman Purified hematopoietic stem cell engraftment of rare niches corrects severe lymphoid deficiencies without host conditioning J. Exp. Med., January 23, 2006; 203(1): 73 - 85. [Abstract] [Full Text] [PDF]

				H. Xu, B. G. Exner, P. M. Chilton, C. Schanie, and S. T. Ildstad CD45 Congenic Bone Marrow Transplantation: Evidence for T Cell-Mediated Immunity Stem Cells, November 1, 2004; 22(6): 1039 - 1048. [Abstract] [Full Text] [PDF]

				R. van Os, G. de Haan, H. Ito, and M. Sykes The balance among immune suppression, stem cell ablation, competition, and engraftment Blood, April 1, 2004; 103(7): 2859 - 2859. [Full Text] [PDF]

				H. Ito, Y. Takeuchi, J. Shaffer, and M. Sykes Local irradiation enhances congenic donor pluripotent hematopoietic stem cell engraftment similarly in irradiated and nonirradiated sites Blood, March 1, 2004; 103(5): 1949 - 1954. [Abstract] [Full Text] [PDF]

				G. Andersson, B. M. W. Illigens, K. W. Johnson, D. Calderhead, C. LeGuern, G. Benichou, M. E. White-Scharf, and J. D. Down Nonmyeloablative conditioning is sufficient to allow engraftment of EGFP-expressing bone marrow and subsequent acceptance of EGFP-transgenic skin grafts in mice Blood, June 1, 2003; 101(11): 4305 - 4312. [Abstract] [Full Text] [PDF]

				E. J. K. Noach, A. Ausema, J. H. Dillingh, B. Dontje, E. Weersing, I. Akkerman, E. Vellenga, and G. de Haan Growth factor treatment prior to low-dose total body irradiation increases donor cell engraftment after bone marrow transplantation in mice Blood, June 17, 2002; 100(1): 312 - 317. [Abstract] [Full Text] [PDF]

				J. R. Timoshanko, S. R. Holdsworth, A. R. Kitching, and P. G. Tipping IFN-{gamma} Production by Intrinsic Renal Cells and Bone Marrow-Derived Cells Is Required for Full Expression of Crescentic Glomerulonephritis in Mice J. Immunol., April 15, 2002; 168(8): 4135 - 4141. [Abstract] [Full Text] [PDF]